Nutrition intervention for the patient with gastroparesis: An update

Practical Gastroenterology

Volumn 29, Issue 8, 2005, Pages 29-66

  Parrish, Carol Rees ^a   Yoshida, Cynthia M ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM DERIVATIVE; ANTACID AGENT; ANTIEMETIC AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCITONIN; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CITRATE 600 PLUS; CITRICAL; CYANOCOBALAMIN; DEXFENFLURAMINE; DIPHENHYDRAMINE; EXTRA STRENGTH TUMS; FERROUS FUMARATE; FERROUS GLUCONATE; FERROUS SULFATE; GLUCAGON; INTERLEUKIN 1; IRON DERIVATIVE; LEVODOPA; LITHIUM; NARCOTIC AGENT; NICOTINE; OCTREOTIDE; ONDANSETRON; POTASSIUM DERIVATIVE; PROGESTERONE; PROKINETIC AGENT; SEROTONIN UPTAKE INHIBITOR; SUCRALFATE; TRICYCLIC ANTIDEPRESSANT AGENT; TUMS; UNINDEXED DRUG; VIACTIV;

ABDOMINAL PAIN; ANAPHYLACTIC SHOCK; CLINICAL FEATURE; CONSTIPATION; CYANOCOBALAMIN DEFICIENCY; DIARRHEA; DIET THERAPY; DISEASE ASSOCIATION; ENTERIC FEEDING; GASTROINTESTINAL SYMPTOM; HUMAN; HYDRATION; IRON DEFICIENCY ANEMIA; NAUSEA; NUTRITIONAL STATUS; PRACTICE GUIDELINE; REVIEW; STOMACH EMPTYING; STOMACH PARESIS; TREATMENT INDICATION; VOMITING;

EID: 24044451501     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Fontana RJ, Barnett JL. Jejunostomy tube placement in refractory diabetic gastroparesis: a retrospective review. Am J Gastroenterol, 1996;91:2174-2178.
2. Parrish C, Sanfilippo N, Krenitsky J, et al. Nutritional and global assessment of long-term jejunostomy feeding. [Abstract] In: ASPEN 18th Clinical Congress. San Antonio, Texas: Amer Soc Parent Enter Nutrit, 1994:589.
3. Shea SC, McCallum RW, Sarosiek I, et al. Nutritional status in patients receiving gastric electrical stimulation for gastroparesis. [Abstract] Nutr Clin Pract, 2002;17(1):54.
4. Jacober SJ, Narayan A, Strodel WE, et al. Jejunostomy feeding in the management of gastroparesis diabeticorum. Diabetes Care, 1986;9(2):217-219.
5. Devendra D, Millward BA, Travis SP. Diabetic gastroparesis improved by percutaneous endoscopic jejunostomy. Diabetes Care, 2000;23(3):426-427.
6. Hasler WL. Disorders of gastric emptying. In: Yamada T (Ed). Textbook of Gastroenterology 3rd Ed. Lippincott Williams and Wilkins Pub. Philadelphia, PA: 1999;1341-1369.
7. Hasler WL. The Physiology of Gastric Motility and Gastric Emptying. In: Yamada T, (Ed.). Textbook of Gastroenterology. 3rd Ed. Philadelphia, PA: Lippincott Williams & Wilkins: 1999:198-202.
8. Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology, 2004;127(5):1592-1622.
9. Pasricha J, McCallum RW, Farrugia G, Soffer E, Prather C, Hasler W, Olden K, Keith-Ferris J, Forster J, Twillman R, Parrish CR, Cutts T, Bernstein RK, Vinik AI, Lal LS, Abell TL, Parkman H. Gastroparesis: Consensus Guidelines for Treatment. American Motility Society and GDPA. 2005 (manuscript in progress).
10. Shopbell JM, Hopkins B, Shronts EP. Nutrition screening and assessment. In: The Science and Practice of Nutrition Support: A Case-Based Core Curriculum. Gottschlich M, (Ed). Kendall/Hunt, 2001:119.
11. National Institutes of Health, National Heart, Lung, and Blood Institute Website: http://nhlbisupport.com/bmi/bmicalc.htm. Accessed April 25, 2005.
12. Horowitz M, Harding PE, Maddox AF, et al. Gastric and esophageal emptying in patients with type II (non-insulin dependent) DM. Diabetologia, 1989;32(3):151-159.
13. MacGregor IL, Gueller R, Watts HD, et al. The effect of acute hyperglycemia on gastric emptying in man. Gastroenterology, 1976;70:190-197.
14. Meyer J. Chronic Morbidity after Ulcer Surgery. In: Sleisenger & Fordtran, (Ed.). Gastrointestinal Diseases 5th Ed, Saunders, Philadelphia, PA 1994:731-744.
15. Fischer AB. Twenty-five years after Billroth II gastrectomy for duodenal ulcer. World J Surg, 1984;8:293-302.
16. Tovey F, Godfrey J, Lwein M. A gastrectomy population: 25-30 years on. Postgrad Med. 1990;66:450-456.
17. Stael von Holstein C, Ibrahimbegovic E, Walther B, et al. Nutrient intake and biochemical markers of nutritional status during long-term follow-up after total and partial gastrectomy. Eur J Clin Nutr, 1992;46:265-272.
18. Pawson R, Mehta A. Review article: The diagnosis and treatment of haematinic deficiency in gastrointestinal disease. Aliment Pharmacol Therap, 1998;12:687-698.
19. Harju E. Metabolic Problems after Gastric Surgery. Int Surg, 1990;75:27-35.
20. Hallberg L, Brune M, Rossander-Hulthen L. Is there a physiologic role of vitamin C in iron absorption? Ann NY Acad Sci, 1987;498:324-332.
21. Langdon DE. Liquid and chewable iron in post-gastrectomy anaemia. (Letter to the Editors) Aliment Pharmacol Therap, 1999;13:567.
22. Rege RV, Jones DB. Current Role of Surgery in Peptic Ulcer Disease. In: Sleisenger & Fordtran, Ed. Gastrointestinal and Liver Disease (CD-ROM). 7th Ed. Elsevier Science; 2002.
23. Adachi S, Kawamoto T, Otsuka M, et al. Enteral Vitamin B12 Supplements Reverse Postgastrectomy B12 Deficiency. Ann Surg, 2000;232:199-201.
24. Radigan A. Post-gastrectomy: Managing the nutrition fall-out. Pract Gastroenterol, 2004:28(6):63.
25. Vestergaard P. Bone loss associated with gastrointestinal disease: prevalence and pathogenesis. Eur J Gastroenterol Hepatol, 2003;15:851-856.
26. Klein KB, Orwoll ES, Lieberman DA, et al. Metabolic bone disease in asymptomatic men after partial gastrectomy with Billroth II anastomosis. Gastroenterology, 1987;92:608-616.
27. Bernstein C, Leslie W. The pathophysiology of bone disease in gastrointestinal disease. Eur J Gastroenterol Hepatol, 2003;15: 857-864.
28. Arden NK, Cooper C. Assessment of the risk of fracture in patients with gastrointestinal disease. Eur J Gastroenterol Hepatol, 2003;15:865-868.
29. McCray S. Lactose Intolerance: Considerations for the Clinician. Pract Gastroenterol, 2003:29;21-39.
30. Fuhrman MP, Charney P, Mueller C. Hepatic Proteins and Nutrition Assessment. J Amer Diet Assoc, 2004;104:1258-1264.
31. Parrish CR, Krenitsky J, McCray S. University of Virginia Health System Nutrition Support Traineeship Syllabus, 2003. Available at: http://www. healthsystem.virginia.edu/internet/dietitian/dh/traineeship.cfm.
32. Urbin JLC, Maurer AH. The Stomach. In: Wagner HN, Szabo Z, Buchanan JW (Eds.). Principles of Nuclear Medicine, 2nd Ed. WB Saunders; Philadelphia, PA. 1995:916-918.
33. Petrakis IE, Chalkiadakis G, Vrachassotakis N, et al. Induced-hyperglycemia attenuates erythromycin-induced acceleration of hypertonic liquid-phase gastric emptying in type I diabetic patients. Dig Dis Sci, 1999;17:241-247.
34. Jones KL, Berry M, Kong MF, et al. Hyperglycemia attenuates the gastrokinetic effect of erythromycin and affects the perception of postprandial hunger in normal subjects. Diabetes Care, 1999;22:339-344.
35. Sanders MK. Bezoars: From Mystical Charms to Medical and Nutritional Management. Practical Gastroenterol, 2004:28(1):37.
36. Rider JA, Foresti-Lorente RF, Garrido J, et al. Gastric bezoars: Treatment and prevention. Am J Gastroenterol, 1984;79:357-359.
37. Parrish CR. Enteral Feeding: The Art and the Science. Nutr Clin Pract, 2003;18:76.
38. Zaidel O, Lin HC. Uninvited Guests: The Impact of Small Intestinal Bacterial Overgrowth on Nutritional Status. Practical Gastroenterology, 2003;27(7):27.
39. Cuoco L, Montalto M, Jorizzo RA, et al. Eradication of small intestinal bacterial overgrowth and oro-cecal transit in diabetics. HepatoGastroenterology, 2002;49:1582-1586.
40. Stefano M, Malservisl S, Veneto G, et al. Rifaximin versus chlortetracycline in the short-term treatment of small bowel intestinal bacterial overgrowth. Aliment Pharmacol Ther, 2000;14(5):551-556.
41. Van Citters GW, Lin HC. The ileal brake: A fifteen-year progress report. Curr Gastroenterol Rep, 1999;1:404-409.
42. Taylor JR, Streetman DS, Castle SS. Medication bezoars: A literature review and report of a case. Ann Pharmacother, 1998;32:940-946.
43. Delpre G, Radish U, Glanz I. Metoclopramide in the treatment of gastric bezoars. Am J Gastroenterol, 1984;79:739-740.
44. Braunschweig CL, Levy P, Sheean PM, et al. Enteral compared with parenteral nutrition: a meta-analysis. Am J Clin Nutr, 2001;74:534-542.
45. Shike M, Latkany L, Gerdes H, et al. Direct percutaneous endoscopic jejunostomies for enteral feeding. Gastrointest Endosc, 1996;44:536-540.
46. McCray S, Walker S, Parrish CR. Much ado about refeeding. Practical Gastroenterology, 2004;28(12):26.
47. Drude Jr. RB, Hines Jr. C. The pathophysiology of intestinal bacterial overgrowth syndromes. Arch Intern Med, 1980;140:1349-1352.
48. Riepe SP, Goldstein J, Alpers DH. Effect of secreted Bacteroides proteases on human intestinal brush border hydrolases. J Clin Invest, 1980;66:314-322.
49. Malone AM. Enteral Formula Selection: A Review of Selected Product Categories. Practical Gastroenterology, 2005;29(6):44.
50. Craig LD, Nicholson S, SilVerstone FA, et al. Use of a Reduced-Carbohydrate, Modified-Fat Enteral Formula for Improving Metabolic Control and Clinical Outcomes in Long-Term Care Residents with Type 2 Diabetes: Results of a Pilot Trial. Nutrition, 1998;14(6):529-534.
51. Tighe MJ, Wong C, Martin IG, et al. Do heparin, hydrocortisone, and glyceryl trinitrate influence thrombophlebitis during full intravenous nutrition via a peripheral vein? J Parenter Enteral Nutr, 1995;19(6):507-509.
52. Timmer JG, Schipper HG. Peripheral Venous Nutrition: The Equal Relevance of Volume Load and Osmolarity in relation to phlebitis. Clin Nutr, 1991;10:71-75.
53. Jones MP. Management of diabetic gastroparesis. Nutr Clin Pract, 2004;19:145-153.
54. Quigley EMM. Gastric motor and sensory function, and motor disturbances of the stomach. In: Feldman M, Friedman LS, Sleisinger MH (Eds.). Gastrointestinal and Liver Disease: Pathology/Diagnosis/Management. Saunders; Philadelphia, PA. 2002;1:691-713.